XML 351 R8.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Convertible debt
Private placement
At-the-market (ATM) distributions
Common Stock
Common Stock
Convertible debt
Common Stock
Private placement
Common Stock
At-the-market (ATM) distributions
Subscription Receivable
Subscription Receivable
Share purchase warrants
Equity Portion of Convertible Promissory Note
Equity Portion of Convertible Promissory Note
Convertible debt
Additional Paid- in-Capital
Additional Paid- in-Capital
Share purchase warrants
Additional Paid- in-Capital
Private placement
Accumulated Deficit
Accumulated Other Comprehensive Loss
Noncontrolling Interests
Beginning balance at Dec. 31, 2021 $ 137,573       $ 163,528       $ 0   $ 0   $ 15,463     $ (40,690) $ (728) $ 0
Beginning balance (in shares) at Dec. 31, 2021         98,903,000                          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Net loss (23,155)                             (23,155)    
Shares issued (in shares)       495,765     6,536,000                      
Shares issued     $ 19,825       $ 19,825                      
Warrants issued in conjunction with private placement 4,177                       4,177          
Share issuance costs (1,534)       $ (2,234)               700          
Shares issued for exercise of warrants and convertible promissory notes to shares (in shares)         2,291,642                          
Shares issued for exercise of warrants and convertible promissory notes to shares $ 2,453       $ 5,323               (2,870)          
Shares issued for exercise of stock options (in shares) 1,016,436       1,016,000                          
Shares issued for exercise of stock options $ 1,193       $ 3,906               (2,713)          
Share-based compensation $ 4,332                       4,332          
Shares issued for services (in shares) 193,348       193,000                          
Shares issued for services $ 611       $ 611                          
Share subscriptions received 51,559               51,559                  
Cumulative translation adjustment (1,457)                               (1,457)  
Ending balance (in shares) at Dec. 31, 2022         108,940,000                          
Ending balance at Dec. 31, 2022 195,577       $ 190,959       51,559   0   19,089     (63,845) (2,185) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Net loss (25,611)                             (25,611)    
Shares issued (in shares)       15,690,943     10,616,000 15,691,000                    
Shares issued     20,209 $ 49,444     $ 20,209 $ 49,444                    
Warrants issued in conjunction with private placement     5,353             $ (18,259)       $ 18,259 $ 5,353      
Share issuance costs (6,283)       $ (7,659)               1,376          
Conversion of subscriptions to shares (in shares)         23,277,000                          
Conversion of subscriptions to shares         $ 33,300       (33,300)                  
Shares issued for exercise of warrants and convertible promissory notes to shares (in shares)         6,034,478                          
Shares issued for exercise of warrants and convertible promissory notes to shares $ 14,968       $ 20,346               (5,378)          
Shares issued for exercise of stock options (in shares) 575,676       576,000                          
Shares issued for exercise of stock options $ 558       $ 1,599               (1,041)          
Share-based compensation 3,464                       3,464          
Equity portion of convertible promissory note 3,813                   3,813              
Fair value of replacement options for Alta Mesa acquisition 81                       81          
Cumulative translation adjustment $ 393                               393  
Ending balance (in shares) at Dec. 31, 2023 165,133,798       165,134,000                          
Ending balance at Dec. 31, 2023 $ 261,966       $ 308,198       0   3,813   41,203     (89,456) (1,792) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Net loss (6,894)                                  
Ending balance at Mar. 31, 2024 360,200                                  
Beginning balance at Dec. 31, 2023 $ 261,966       $ 308,198       0   3,813   41,203     (89,456) (1,792) 0
Beginning balance (in shares) at Dec. 31, 2023 165,133,798       165,134,000                          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Net loss $ (67,993)                             (61,392)   (6,601)
Shares issued (in shares)             2,564,000 496,000                    
Shares issued     $ 10,000 $ 2,008     $ 10,000 $ 2,008                    
Contributions from non-controlling interest 9,987                       8,228         1,759
Inventory distributions to non-controlling interest (1,905)                                 (1,905)
Share issuance costs (50)       $ (50)                          
Shares issued for exercise of warrants and convertible promissory notes to shares (in shares)         8,781,985 6,872,000                        
Shares issued for exercise of warrants and convertible promissory notes to shares $ 25,471 $ 19,304     $ 33,373 $ 23,117           $ (3,813) (7,902)          
Shares issued for exercise of stock options (in shares) 2,267,155       2,267,000                          
Shares issued for exercise of stock options $ 1,760       $ 3,679               (1,919)          
Share-based compensation 4,788                       4,788          
Non-controlling interest Investment in JV Alta Mesa 55,011                       15,458         39,553
Cumulative translation adjustment $ (1,805)                               (1,805)  
Ending balance (in shares) at Dec. 31, 2024 186,114,948       186,115,000                          
Ending balance at Dec. 31, 2024 $ 318,542       $ 380,325       0   0   59,856     (150,848) (3,597) 32,806
Beginning balance at Mar. 31, 2024 360,200                                  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Net loss (23,904)                                  
Ending balance at Jun. 30, 2024 345,598                                  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Net loss (18,115)                                  
Ending balance at Sep. 30, 2024 332,509                                  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                    
Net loss $ (19,080)                                  
Ending balance (in shares) at Dec. 31, 2024 186,114,948       186,115,000                          
Ending balance at Dec. 31, 2024 $ 318,542       $ 380,325       $ 0   $ 0   $ 59,856     $ (150,848) $ (3,597) $ 32,806